Literature DB >> 4557183

The relation of deoxyribonuclease inhibitor levels to the occurrence of antinuclear antibodies in NZB-NZW mice.

K Hadjiyannaki, P J Lachmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4557183      PMCID: PMC1553626     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  2 in total

Review 1.  The immunology and pathology of NZB mice.

Authors:  J B Howie; B J Helyer
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

2.  The relationship of desoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies.

Authors:  P G Frost; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1968-06       Impact factor: 4.330

  2 in total
  4 in total

1.  Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus.

Authors:  L Raptis; H A Menard
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

2.  The in vivo expression of actin/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus erythematosus.

Authors:  Anthony P Manderson; Francesco Carlucci; Peter J Lachmann; Robert A Lazarus; Richard J Festenstein; H Terence Cook; Mark J Walport; Marina Botto
Journal:  Arthritis Res Ther       Date:  2006-04-10       Impact factor: 5.156

3.  In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus.

Authors:  S Izui; P H Lambert; P A Miescher
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

4.  RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities.

Authors:  Richa Rai; Sudhir Kumar Chauhan; Vikas Vikram Singh; Madhukar Rai; Geeta Rai
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.